FMC Corporation filings document the regulatory record of a NYSE-listed agricultural sciences company with common stock trading under FMC. Recent 8-K reports disclose operating results, material credit-agreement amendments, financial covenants, subsidiary guarantees, collateral arrangements, dividend limitations, restructuring charges, and governance changes.
Proxy materials describe annual meeting matters, stockholder voting procedures, and equity incentive plan approvals. Together, the filings cover FMC's capital structure, board oversight, compensation programs, manufacturing footprint actions, risk-related covenant terms, and recurring financial reporting for its crop protection business.
FMC Corporation director Michael F. Barry reported an open-market purchase of 18,072.191 shares of FMC common stock on March 4, 2026. The weighted average purchase price was $13.83 per share, with individual trades executed between $13.77 and $13.86. Following this transaction, Barry directly owns 19,634.191 FMC shares.
BARRY MICHAEL F reported acquisition or exercise transactions in this Form 4 filing.
FMC Corp director Michael F. Barry received a grant of 1,562 shares of FMC common stock on February 27, 2026. The award was recorded at a price of $0.00 per share, reflecting a stock-based compensation grant rather than an open-market purchase. After this grant, his direct holdings total 1,562 shares.
FMC Corp director Michael F. Barry reported his initial ownership position as of February 27, 2026, showing no FMC common stock held directly and stating that he does not hold any FMC derivative securities. This establishes a baseline disclosure of his current equity stake at zero.
FMC Corporation is soliciting proxies for its 2026 Annual Meeting of Stockholders. The virtual meeting is scheduled for April 28, 2026 at 2:00 p.m. EDT and will be accessible at www.virtualshareholdermeeting.com/FMC2026. The record date for voting was February 27, 2026, and there were 125,045,033 shares of Common Stock outstanding on that date.
The Board asks stockholders to vote on: election of ten directors; ratification of KPMG LLP as auditor; an advisory vote on executive compensation; amendments to the Certificate of Incorporation and By-Laws (including elimination of supermajority provisions and special meeting rights at a 25% threshold); miscellaneous charter changes; and approval of the FMC Corporation 2026 Incentive Stock Plan, which proposes a reserve of 5,250,000 shares plus certain recycled shares and includes limitations such as a fungible share pool and director compensation caps.
FMC Corporation is a global agricultural sciences company focused on crop protection chemicals and plant health products, operating as a single business segment. The company is undergoing a strategic review announced in February 2026 to explore options, including a potential sale, to enhance shareholder value while it executes 2026 priorities such as strengthening the balance sheet and divesting its India commercial business, which is classified as held for sale and expected to close in 2026.
FMC is reshaping its cost base: 2024 restructuring delivered $165 million in savings and the multi‑year Project Foundation aims to optimize manufacturing and reduce structural costs. Growth is anchored by core diamide insecticides, including Rynaxypyr active with about $0.8 billion in 2025 revenue and Cyazypyr active with about $0.4 billion, alongside new herbicide and fungicide molecules and digital tools like the Arc farm intelligence platform.
The company emphasizes sustainability and safety, reporting a Total Recordable Incident Rate of 0.1491 and reducing Highly Hazardous Pesticides to roughly 0.1% of sales. As of December 31, 2025, FMC had about 5,500 employees worldwide and 124,934,056 common shares outstanding, supported by a substantial global patent estate protecting key technologies.
FMC Corp Chairman, CEO and President Pierre R. Brondeau reported a tax-withholding disposition of 4,837 shares of FMC common stock. The shares were disposed of at a price of $14.62 per share to cover tax obligations. After this transaction, he directly holds 568,017 FMC shares.
FMC CORP Executive Vice President and CFO Andrew D. Sandifer reported two tax-related share dispositions under the company’s equity plans. On February 23, 2026, he surrendered 2,814 and 1,719 shares of common stock at $14.62 per share to cover tax liabilities.
After these transactions, he held 147,093 FMC common shares directly, plus 4,620.511 shares held indirectly through a Thrift Plan, based on a plan statement as of February 19, 2026. These Form 4 entries reflect tax-withholding dispositions rather than open-market sales.
FMC Corp EVP & Chief Technology Officer Vsevolod Rostovtsev reported tax-related share dispositions. On February 23, 2026, he delivered 1,059 shares of FMC common stock at $14.62 per share to cover tax obligations. A second tax-withholding disposition on the same date involved 334 shares at $14.62 per share. After these transactions, his directly held common stock positions reported were 39,259 shares and then 38,925 shares.
FMC Corp executive Jacqueline Scanlan, Executive VP & Chief HRO, reported a tax-related share disposition. On this Form 4, 1,404 shares of common stock were disposed of at $14.62 per share as a tax-withholding transaction. After this, her directly owned stake is 68,695 shares.
FMC Corp officer Nicholas Pfeiffer reported tax-related share dispositions rather than open-market sales. On February 23, 2026, he disposed of 488 and 395 shares of common stock at $14.62 per share to cover tax liabilities. After these transactions, he held 29,764 shares directly and 549.972 shares indirectly through a Thrift Plan based on a statement as of February 19, 2026.